However, there are exceptions, which leave out some large countries. For example, although a Brazilian company could obtain the license to manufacture the pill and export it to other countries, the drug cannot be manufactured generically for use in Brazil.
However, specialists said that the fact that the agreement was reached before the Pfizer pill was authorized, this could contribute to a faster end to the pandemic.
A spokesman for Unitaid, an international initiative that promotes access to treatment for diseases such as AIDS, malaria and tuberculosis in populations of developing countries and which created the MPP, said that manufacturers of generic drugs “who receive sublicenses They will be able to offer the new drug in association with ritonavir, used against the AIDS virus. “
The drug may be marketed “in 95 countries, which cover about 53% of the world’s population,” added the spokesman during a meeting with the UN press in Geneva.
At the beginning of November, the company, which already markets one of the most effective vaccines against coronavirus with the German group BioNTech, indicated that its oral antiviral PF-07321332 was 89% effective in preventing hospitalization or death among adults who They are at high risk of developing a severe form of the disease, based on intermediate results of clinical trials.
With this agreement, it is advancing on the same path as its competitor Merck, which signed a similar agreement with MPP for its own oral anticovid, molnupiravir, which also exhibits a high rate of efficacy.
Source From: Ambito
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.
